Adam Simning1, Yeates Conwell2, Supriya G Mohile3, Edwin van Wijngaarden4. 1. Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, NY. Electronic address: adam_simning@urmc.rochester.edu. 2. Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, NY; Office for Aging Research and Health Services, University of Rochester Medical Center, Rochester, NY. 3. Department of Medicine, Hematology/Oncology Division, University of Rochester School of Medicine and Dentistry, Rochester, NY. 4. Department of Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Abstract
OBJECTIVE: To determine how age may modulate the association of a history of cancer with a 12-month history of anxiety and depressive disorders. METHODS: The authors used population-based, cross-sectional surveys, the Collaborative Psychiatric Epidemiology Surveys. These surveys were conducted in the United States in 2001-2003 and included 16,423 adult participants, of whom 702 reported a cancer history. The Composite International Diagnostic Interview evaluated the presence of a 12-month history of anxiety and depressive disorders. RESULTS: Among those with a cancer history, older adults (≥60 years old) were less likely than younger adults (18-59 years old) to have a 12-month history of an anxiety or depressive disorder. Compared with their peers without cancer, younger adults with a cancer history had more anxiety (23.8% versus 13.9%) and depressive (16.0% versus 9.5%) disorders, whereas older adults with a cancer history had lower levels of anxiety (3.7% versus 6.3%) and depressive (1.9% versus 3.9%) disorders. In multivariable modeling, there was a statistically significant interaction between age group and cancer history, with the risk for anxiety and depressive disorders elevated in the younger age group with a cancer history (odds ratio: 5.84 and odds ratio: 6.13, respectively) but decreased in the older age group with a cancer history (odds ratio: 0.55 and odds ratio: 0.45, respectively). CONCLUSION: The authors' findings suggest a considerable age-dependent variation with regard to anxiety and depressive disorders in adults with a cancer history. Investigation of the mechanisms contributing to this apparent age differential in risk could have important mental illness treatment implications in this population.
OBJECTIVE: To determine how age may modulate the association of a history of cancer with a 12-month history of anxiety and depressive disorders. METHODS: The authors used population-based, cross-sectional surveys, the Collaborative Psychiatric Epidemiology Surveys. These surveys were conducted in the United States in 2001-2003 and included 16,423 adult participants, of whom 702 reported a cancer history. The Composite International Diagnostic Interview evaluated the presence of a 12-month history of anxiety and depressive disorders. RESULTS: Among those with a cancer history, older adults (≥60 years old) were less likely than younger adults (18-59 years old) to have a 12-month history of an anxiety or depressive disorder. Compared with their peers without cancer, younger adults with a cancer history had more anxiety (23.8% versus 13.9%) and depressive (16.0% versus 9.5%) disorders, whereas older adults with a cancer history had lower levels of anxiety (3.7% versus 6.3%) and depressive (1.9% versus 3.9%) disorders. In multivariable modeling, there was a statistically significant interaction between age group and cancer history, with the risk for anxiety and depressive disorders elevated in the younger age group with a cancer history (odds ratio: 5.84 and odds ratio: 6.13, respectively) but decreased in the older age group with a cancer history (odds ratio: 0.55 and odds ratio: 0.45, respectively). CONCLUSION: The authors' findings suggest a considerable age-dependent variation with regard to anxiety and depressive disorders in adults with a cancer history. Investigation of the mechanisms contributing to this apparent age differential in risk could have important mental illness treatment implications in this population.
Authors: Steven G Heeringa; James Wagner; Myriam Torres; Naihua Duan; Terry Adams; Patricia Berglund Journal: Int J Methods Psychiatr Res Date: 2004 Impact factor: 4.035
Authors: James S Jackson; Myriam Torres; Cleopatra H Caldwell; Harold W Neighbors; Randolph M Nesse; Robert Joseph Taylor; Steven J Trierweiler; David R Williams Journal: Int J Methods Psychiatr Res Date: 2004 Impact factor: 4.035
Authors: D A Regier; J H Boyd; J D Burke; D S Rae; J K Myers; M Kramer; L N Robins; L K George; M Karno; B Z Locke Journal: Arch Gen Psychiatry Date: 1988-11
Authors: Shae E Quirk; Renée El-Gabalawy; Sharon L Brennan; James M Bolton; Jitender Sareen; Michael Berk; Andrew M Chanen; Julie A Pasco; Lana J Williams Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2014-10-15 Impact factor: 4.328